ArticleCureus2026
Incidence of Heterotopic Ossification Following Double-Incision Technique for Distal Biceps Tendon Repair.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Heterotopic ossification (HO) is a postoperative finding that may occur after distal biceps tendon repair using the double-incision technique; however, its incidence, temporal evolution, and clinical relevance remain incompletely defined. Objectives The objectives of this study are to determine the incidence and temporal evolution of heterotopic ossification (HO), evaluate variables associated with its development, and assess clinical outcomes following double-incision distal biceps tendon repair performed under a standardized postoperative protocol including non-steroidal anti-inflammatory drug (NSAID) prophylaxis. Methods A retrospective cohort study was performed including 94 patients with complete distal biceps tendon rupture treated surgically with a double-incision technique between January 2018 and July 2023. All patients had a minimum follow-up of 24 weeks and underwent serial radiographic evaluation at two, four, eight, 12, and 24 weeks postoperatively. HO was identified radiographically, and patients were grouped according to its presence. Functional outcomes were assessed using the Mayo Elbow Performance Score (MEPS). Clinical outcomes, need for additional surgery, and associated risk factors were analyzed. Results HO developed in 11 patients (11.7%), with spontaneous resorption observed in 54.5% of cases. Patients without HO achieved a mean MEPS of 97.8±2.5, whereas those with spontaneous HO resorption achieved a mean MEPS of 94.2±2.0. Persistent HO treated nonoperatively demonstrated a mean MEPS of 83.3±2.9, while surgically treated patients achieved a postoperative mean MEPS of 90.0±0. Only two patients (2.1%) required surgical excision. Anabolic steroid use and a delay greater than 10 days between injury and surgery were significantly associated with HO development (p<0.001). Conclusion The double-incision technique is associated with the development of HO; however, most cases follow a favorable and self-limited course with frequent spontaneous resorption and preservation of functional outcomes. Persistent symptomatic HO may result in functional limitation and occasionally require surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.